SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF KIDNEY DISEASES
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-09-09
DOI
10.1053/j.ajkd.2021.08.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
- (2021) Michael J. Joyner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Kinetics of Anti–SARS-CoV-2 IgG Antibodies in Hemodialysis Patients Six Months after Infection
- (2021) Hamza Sakhi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Humoral Response to the Pfizer BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis
- (2021) Ayelet Grupper et al. Clinical Journal of the American Society of Nephrology
- Antibody response to mRNA SARS-CoV-2 vaccine among dialysis patients—a prospective cohort study
- (2021) Timna Agur et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Covid-19: Stronger warnings are needed to curb socialising after vaccination, say doctors and behavioural scientists
- (2021) Michael Day BMJ-British Medical Journal
- Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma
- (2021) Sarah Bird et al. Lancet Haematology
- SARS-CoV-2 vaccination in rituximab-treated patients: B cells promote humoral immune responses in the presence of T-cell-mediated immunity
- (2021) Daniel Mrak et al. ANNALS OF THE RHEUMATIC DISEASES
- Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer
- (2021) Thomas Mueller CLINICA CHIMICA ACTA
- Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients
- (2021) Philippe Attias et al. KIDNEY INTERNATIONAL
- Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy
- (2021) T. Alp Ikizler et al. KIDNEY INTERNATIONAL
- Experience with SARS-CoV-2 BNT162b2 mRNA vaccine in dialysis patients
- (2021) Noa Berar Yanay et al. KIDNEY INTERNATIONAL
- Longevity of SARS-CoV-2 immune responses in hemodialysis patients and protection against reinfection
- (2021) Candice L. Clarke et al. KIDNEY INTERNATIONAL
- Neutralizing SARS-CoV-2 antibody response in dialysis patients after the first dose of the BNT162b2 mRNA COVID-19 vaccine: the war is far from being won
- (2021) Massimo Torreggiani et al. KIDNEY INTERNATIONAL
- Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
- (2021) Nassim Kamar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients
- (2021) José Jesús Broseta et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Vulnerabilities in kidney transplant recipients with COVID‐19: a single center experience
- (2020) Soufian Meziyerh et al. TRANSPLANT INTERNATIONAL
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
- (2020) Sheila F. Lumley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Maladie rénale chronique et immunosénescence prématurée : données et perspectives
- (2019) Thomas Crépin et al. Nephrologie & Therapeutique
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started